olmesartan has been researched along with technetium tc 99m bicisate in 1 studies
| Studies (olmesartan) | Trials (olmesartan) | Recent Studies (post-2010) (olmesartan) | Studies (technetium tc 99m bicisate) | Trials (technetium tc 99m bicisate) | Recent Studies (post-2010) (technetium tc 99m bicisate) |
|---|---|---|---|---|---|
| 841 | 185 | 554 | 691 | 103 | 137 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ikeda, K; Kawabe, K; Nagata, R | 1 |
1 other study(ies) available for olmesartan and technetium tc 99m bicisate
| Article | Year |
|---|---|
Olmesartan, an angiotensin II receptor blocker, restores cerebral hypoperfusion in elderly patients with hypertension.
Topics: Aged; Aged, 80 and over; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Blood Pressure; Brain; Cerebrovascular Circulation; Cysteine; Female; Humans; Hypertension; Imidazoles; Magnetic Resonance Imaging; Male; Organotechnetium Compounds; Tetrazoles; Tomography, Emission-Computed, Single-Photon | 2010 |